These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 33175396)

  • 21. Imaging counterpart of postural instability and vertical ocular dysfunction in patients with PSP: A multimodal MRI study.
    Quattrone A; Caligiuri ME; Morelli M; Nigro S; Vescio B; Arabia G; Nicoletti G; Nisticò R; Salsone M; Novellino F; Barbagallo G; Vaccaro MG; Sabatini U; Vescio V; Stanà C; Rocca F; Caracciolo M; Quattrone A
    Parkinsonism Relat Disord; 2019 Jun; 63():124-130. PubMed ID: 30803901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Uncovering clinical and radiological asymmetry in progressive supranuclear palsy-Richardson's syndrome.
    Picillo M; Tepedino MF; Abate F; Ponticorvo S; Erro R; Cuoco S; Oksuz N; Di Salle G; Di Salle F; Esposito F; Pellecchia MT; Manara R; Barone P
    Neurol Sci; 2022 Jun; 43(6):3677-3682. PubMed ID: 35106692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Theta burst stimulation modulates cerebellar-cortical connectivity in patients with progressive supranuclear palsy.
    Brusa L; Ponzo V; Mastropasqua C; Picazio S; Bonnì S; Di Lorenzo F; Iani C; Stefani A; Stanzione P; Caltagirone C; Bozzali M; Koch G
    Brain Stimul; 2014; 7(1):29-35. PubMed ID: 23928103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Features of Patients With Nonfluent/Agrammatic Primary Progressive Aphasia With Underlying Progressive Supranuclear Palsy Pathology or Corticobasal Degeneration.
    Santos-Santos MA; Mandelli ML; Binney RJ; Ogar J; Wilson SM; Henry ML; Hubbard HI; Meese M; Attygalle S; Rosenberg L; Pakvasa M; Trojanowski JQ; Grinberg LT; Rosen H; Boxer AL; Miller BL; Seeley WW; Gorno-Tempini ML
    JAMA Neurol; 2016 Jun; 73(6):733-42. PubMed ID: 27111692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of impaired subcortico-frontal metabolic networks in normal aging, subcortico-frontal dementia, and cortical frontal dementia.
    Garraux G; Salmon E; Degueldre C; Lemaire C; Laureys S; Franck G
    Neuroimage; 1999 Aug; 10(2):149-62. PubMed ID: 10417247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Magnetic Resonance Parkinsonism Index for evaluating disease progression rate in progressive supranuclear palsy: A longitudinal 2-year study.
    Quattrone A; Morelli M; Quattrone A; Vescio B; Nigro S; Arabia G; Nisticò R; Novellino F; Salsone M; Arcuri P; Luca A; Mazzuca A; Alessio C; Rocca F; Caracciolo M
    Parkinsonism Relat Disord; 2020 Mar; 72():1-6. PubMed ID: 32036297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intrinsic connectivity network disruption in progressive supranuclear palsy.
    Gardner RC; Boxer AL; Trujillo A; Mirsky JB; Guo CC; Gennatas ED; Heuer HW; Fine E; Zhou J; Kramer JH; Miller BL; Seeley WW
    Ann Neurol; 2013 May; 73(5):603-16. PubMed ID: 23536287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new MR imaging index for differentiation of progressive supranuclear palsy-parkinsonism from Parkinson's disease.
    Quattrone A; Morelli M; Nigro S; Quattrone A; Vescio B; Arabia G; Nicoletti G; Nisticò R; Salsone M; Novellino F; Barbagallo G; Le Piane E; Pugliese P; Bosco D; Vaccaro MG; Chiriaco C; Sabatini U; Vescio V; Stanà C; Rocca F; Gullà D; Caracciolo M
    Parkinsonism Relat Disord; 2018 Sep; 54():3-8. PubMed ID: 30068492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased basal ganglia binding of
    Smith R; Schain M; Nilsson C; Strandberg O; Olsson T; Hägerström D; Jögi J; Borroni E; Schöll M; Honer M; Hansson O
    Mov Disord; 2017 Jan; 32(1):108-114. PubMed ID: 27709757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Instability of syllable repetition in progressive supranuclear palsy.
    Skodda S; Grönheit W; Schlegel U
    J Neural Transm (Vienna); 2012 Apr; 119(4):457-62. PubMed ID: 22065210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brain volume and flortaucipir analysis of progressive supranuclear palsy clinical variants.
    Whitwell JL; Tosakulwong N; Botha H; Ali F; Clark HM; Duffy JR; Utianski RL; Stevens CA; Weigand SD; Schwarz CG; Senjem ML; Jack CR; Lowe VJ; Ahlskog JE; Dickson DW; Josephs KA
    Neuroimage Clin; 2020; 25():102152. PubMed ID: 31935638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reproducible network and regional topographies of abnormal glucose metabolism associated with progressive supranuclear palsy: Multivariate and univariate analyses in American and Chinese patient cohorts.
    Ge J; Wu J; Peng S; Wu P; Wang J; Zhang H; Guan Y; Eidelberg D; Zuo C; Ma Y
    Hum Brain Mapp; 2018 Jul; 39(7):2842-2858. PubMed ID: 29536636
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Eye movements and association with regional brain atrophy in clinical subtypes of progressive supranuclear palsy.
    Choi JH; Kim H; Shin JH; Lee JY; Kim HJ; Kim JM; Jeon B
    J Neurol; 2021 Mar; 268(3):967-977. PubMed ID: 32959131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atrophy in midbrain & cerebral/cerebellar pedunculi is characteristic for progressive supranuclear palsy - A double-validation whole-brain meta-analysis.
    Albrecht F; Bisenius S; Neumann J; Whitwell J; Schroeter ML
    Neuroimage Clin; 2019; 22():101722. PubMed ID: 30831462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuroimaging correlates of postural instability in Progressive Supranuclear Palsy.
    Calomino C; Quattrone A; Sarica A; Bianco MG; Aracri F; De Maria M; Buonocore J; Vaccaro MG; Vescio B; Quattrone A
    Parkinsonism Relat Disord; 2023 Aug; 113():105768. PubMed ID: 37480615
    [TBL] [Abstract][Full Text] [Related]  

  • 36. White matter and cortical changes in atypical parkinsonisms: A multimodal quantitative MR study.
    Zanigni S; Evangelisti S; Testa C; Manners DN; Calandra-Buonaura G; Guarino M; Gabellini A; Gramegna LL; Giannini G; Sambati L; Cortelli P; Lodi R; Tonon C
    Parkinsonism Relat Disord; 2017 Jun; 39():44-51. PubMed ID: 28291592
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Connectome analysis with diffusion MRI in idiopathic Parkinson's disease: Evaluation using multi-shell, multi-tissue, constrained spherical deconvolution.
    Kamagata K; Zalesky A; Hatano T; Di Biase MA; El Samad O; Saiki S; Shimoji K; Kumamaru KK; Kamiya K; Hori M; Hattori N; Aoki S; Pantelis C
    Neuroimage Clin; 2018; 17():518-529. PubMed ID: 29201640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy.
    Boxer AL; Geschwind MD; Belfor N; Gorno-Tempini ML; Schauer GF; Miller BL; Weiner MW; Rosen HJ
    Arch Neurol; 2006 Jan; 63(1):81-6. PubMed ID: 16401739
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frontal presentation in progressive supranuclear palsy.
    Donker Kaat L; Boon AJ; Kamphorst W; Ravid R; Duivenvoorden HJ; van Swieten JC
    Neurology; 2007 Aug; 69(8):723-9. PubMed ID: 17709703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved Automatic Morphology-Based Classification of Parkinson's Disease and Progressive Supranuclear Palsy.
    Talai AS; Ismail Z; Sedlacik J; Boelmans K; Forkert ND
    Clin Neuroradiol; 2019 Dec; 29(4):605-614. PubMed ID: 30218110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.